Insiders Bristol-Myers Squibb Company Deutsche Boerse AG

Equities

BRM

US1101221083

Real-time Estimate Tradegate Other stock markets 01:48:36 27/06/2024 pm IST			5-day change	1st Jan Change
39.93 ^EUR	+0.69%		+3.59%	-15.09%

26/06	2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	MT
26/06	Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bristol Myers: ex-CEO of Agilent joins Board of Directors	19/06	CF
Bristol Myers Squibb Appoints Michael R. McMullen as Independent Director and Member of the Audit Committee, Effective July 1, 2024	19/06	CI
Germany's Evotec appoints Christian Wojczewski as CEO	24/04	RE
Novartis Nominates Former Bristol Myers Squibb CEO as New Chair	23/04	MT
Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand	23/04	MT
Bristol-Myers Squibb Company Announces Gerald Storch Not to Stand for Re-Election to the Board	19/03	CI
Arvinas Appoints Noah Berkowitz as Chief Medical Officer	19/03	MT
Aurora Cannabis Names Simona King CFO; Completes Share Consolidation	20/02	MT
Bristol-Myers Squibb Company Announces Management Changes	16/02	CI
Lonza chairman to step down, drugmaker confirms targets, shares soar	26/01	RE
Evotec says it promptly reported share trades withheld by former CEO	22/01	RE
Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology	09/01	MT
Avacta taps biopharma veteran as Therapeutics business chief	19/12	AN
UniCredit seeks new chair candidate by early 2024, sources say	07/12	RE
UniCredit seeks new presidential candidate by early 2024 - sources	06/12	RE
UniCredit seeks new chair candidate by early 2024, sources say	06/12	RE
Bristol Myers Squibb Insider Bought Shares Worth $150,049, According to a Recent SEC Filing	01/12	MT
Bristol Myers Squibb Insider Bought Shares Worth $423,385, According to a Recent SEC Filing	22/11	MT
Bristol-Myers Squibb Names Christopher Boerner as Chair	01/11	MT
Bristol Myers Names Incoming CEO Boerner as Next Chairman	01/23/01	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 11:36 pm IST